BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update

  May 11, 2026

   · 

  12 min read
• Press Releases

  Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

  May 11, 2026

   · 

  8 min read
• Press Releases

  Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

  May 11, 2026

   · 

  12 min read
• Press Releases

  Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

  May 11, 2026

   · 

  8 min read
• Press Releases

  Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago

  May 11, 2026

   · 

  5 min read
• Press Releases

  Corvention Announces FDA 510(k) Clearance for the KardiaPSI™ Balloon Catheter

  May 11, 2026

   · 

  3 min read
• Press Releases

  Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

  May 11, 2026

   · 

  6 min read
• Press Releases

  Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)

  May 11, 2026

   · 

  6 min read
• Press Releases

  Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

  May 11, 2026

   · 

  12 min read
• Press Releases

  United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026

  May 11, 2026

   · 

  5 min read